0001209191-23-051393.txt : 20231003
0001209191-23-051393.hdr.sgml : 20231003
20231003160526
ACCESSION NUMBER: 0001209191-23-051393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230929
FILED AS OF DATE: 20231003
DATE AS OF CHANGE: 20231003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Subramanian Sanjay
CENTRAL INDEX KEY: 0001790246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39397
FILM NUMBER: 231303501
MAIL ADDRESS:
STREET 1: 5 GREAT VALLEY PARKWAY, SUITE 160
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inozyme Pharma, Inc.
CENTRAL INDEX KEY: 0001693011
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475129768
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 SUMMER STREET
STREET 2: SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-330-4340
MAIL ADDRESS:
STREET 1: 321 SUMMER STREET
STREET 2: SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Inozyme Pharma, LLC
DATE OF NAME CHANGE: 20161222
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-29
0
0001693011
Inozyme Pharma, Inc.
INZY
0001790246
Subramanian Sanjay
C/O INOZYME PHARMA, INC.
321 SUMMER STREET, SUITE 400
BOSTON
MA
02210
0
1
0
0
SVP, CFO
0
Common Stock
2023-09-29
5
A
0
E
2319
3.57
A
30398
D
Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2023 through September 30, 2023. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on September 29, 2023, the last trading day of the purchase period.
/s/ Sanjay S. Subramanian
2023-10-03